JUL 19, 2022 9:34 AM PDT

Experimental Cancer Drug Regrows Nerves in Spinal Cord Injury

WRITTEN BY: Annie Lennon

An experimental cancer drug can regenerate damaged nerves following spinal trauma in mice and rats. The corresponding report was published in Clinical and Translational Medicine

Spinal cord injury affects between 200,000 and 1.2 million people per year and currently has no cure. Key issues in treating the condition include the low capacity of neurons in the central nervous system to regrow after injury and the presence of extrinsic factors such as myelin and scar-derived inhibitory molecules around regenerating axons.

Pharmaceutical company AstraZeneca is currently investigating a drug candidate known as AZD1390 that works by blocking ATM-dependent signaling and repair of DNA double-strand breaks to sensitize cancer cells to radiation treatment. In the current report, researchers hypothesized that the drug might also be able to promote nerve repair and restore function in those with spinal cord injury. 

From cell studies, they found that AZD1390 could stimulate nerve cell growth in cell cultures and inhibit the ATM protein kinase pathway, a critical pathway regulating the response to DNA damage. 

They also tested the drug candidate in mouse and rat models of spinal cord injury, and found that oral treatment resulted in suppression of the ATM protein kinase pathway, nerve regeneration beyond the site of injury, and the ability of nerves to carry electrical signals to the injury site. 

“This is an exciting time in spinal cord injury research with several different investigational drugs being identified as potential therapies for spinal cord injury,” said Professor Zubair Ahmed, from the University of Birmingham’s Institute of Inflammation and Ageing, and one of the authors of the study.

“We are particularly excited about AZD1390, which can be taken orally and reaches the site of injury in sufficient quantities to promote nerve regeneration and restore lost function,” he noted. 

“Our findings show a remarkable recovery of sensory and motor functions, and AZD1390-treated animals being indistinguishable from uninjured animals within 4 weeks of injury,” he added. 

 

Sources: Neuroscience NewsClinical and Translational Medicine

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 09, 2022
Drug Discovery & Development
Universal Vaccine for Influenza B Shows Promise
JUL 09, 2022
Universal Vaccine for Influenza B Shows Promise
A new universal flu vaccine has been shown to protect against influenza B viruses in cell and mouse models. The correspo ...
JUL 14, 2022
Clinical & Molecular DX
Emerging Research Could Soon Solve the Parkinson's Disease Diagnosis Challenge
JUL 14, 2022
Emerging Research Could Soon Solve the Parkinson's Disease Diagnosis Challenge
Parkinson’s disease is a brain disorder with symptoms that begin gradually and worsen over time. Symptoms of Parki ...
AUG 21, 2022
Cannabis Sciences
Synthetic Cannabinoid Poisonings Decrease as More States Legalize Cannabis
AUG 21, 2022
Synthetic Cannabinoid Poisonings Decrease as More States Legalize Cannabis
Synthetic cannabis, also known as Spice, AK-47 or K2, has received extensive news coverage after overdoses and deaths in ...
AUG 30, 2022
Clinical & Molecular DX
Caffeine Metabolite Could Slow Progression of Nearsightedness in Children
AUG 30, 2022
Caffeine Metabolite Could Slow Progression of Nearsightedness in Children
Myopia, also known as nearsightedness, is a common vision condition in which objects far away appear blurry. Myopia occu ...
SEP 23, 2022
Cannabis Sciences
Cannabis Legalization's Impact on Pharmaceutical Stock Market Values
SEP 23, 2022
Cannabis Legalization's Impact on Pharmaceutical Stock Market Values
In states with legal medical cannabis, people are curious about using cannabinoid treatment as an alternative to pharmac ...
SEP 15, 2022
Neuroscience
Food Insecurity Affects Brain Development
SEP 15, 2022
Food Insecurity Affects Brain Development
A recent study found that food insecurity affects brain development in mice. University of California Berkeley researche ...
Loading Comments...